Clayton NS, Grose RP(2018). Emerging Roles of Fibroblast Growth Factor 10 in Cancer. Front Genet vol. 9, 499-499.
Fearon AE, Carter EP, Clayton NS et al.(2018). PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer. Cell Rep vol. 22, (9) 2469-2481.
Clayton NS, Wilson AS, Laurent EP et al.(2017). Fibroblast growth factor-mediated crosstalk in cancer etiology and treatment. Dev Dyn vol. 246, (7) 493-501.
Carter EP, Gopsill JA, Gomm JJ et al.(2017). A 3D in vitro model of the human breast duct: a method to unravel myoepithelial-luminal interactions in the progression of breast cancer. Breast Cancer Res vol. 19, (1)
Chioni A-M, Bajwa RT, Grose R(2017). 3D Organotypic Culture Model to Study Components of ERK Signaling. Methods Mol Biol vol. 1487, 255-267.
Carter E, Gomm JJ, Jones LJ et al. (2016). A 3D in vitro model of the human breast duct: unravelling myoepithelial-luminal interactions in breast cancer. Breast Cancer Research and Treatment. Conference: UK Breast Cancer Research Symposium 2016 vol. 159, 187-188.
Carapuça EF, Gemenetzidis E, Feig C et al.(2016). Anti-stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma. Journal of Pathology vol. 239, (3) 286-296.
GROSE RP, Dawkins JBN, Wang J et al.(2016). Reduced expression of histone methyltransferases KMT2C and KMT2D correlates with improved outcome in pancreatic ductal adenocarcinoma. Cancer Research
Tanner Y, Grose RP(2016). Dysregulated FGF signalling in neoplastic disorders. Seminars in Cell and Developmental Biology vol. 53, Article C, 126-135.
Milagre CS, Gopinathan G, Everitt G et al.(2015). Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer. Cancer Res vol. 75, (7) 1255-1264.
Carter EP, Fearon AE, Grose RP(2015). Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction. Trends Cell Biol vol. 25, (4) 221-233.
Coleman SJ, Bruce C, Chioni A-M et al.(2014). The ins and outs of fibroblast growth factor receptor signalling. Clin Sci (Lond) vol. 127, (4) 217-231.
Coleman SJ, Watt J, Arumugam P et al.(2014). Pancreatic cancer organotypics: High throughput, preclinical models for pharmacological agent evaluation. World J Gastroenterol vol. 20, (26) 8471-8481.
Yeste-Velasco M, Mao X, Grose R et al.(2014). Identification of ZDHHC14 as a novel human tumour suppressor gene. J Pathol vol. 232, (5) 566-577.
Coleman SJ, Chioni A-M, Ghallab M et al.(2014). Nuclear translocation of FGFR1 and FGF2 in pancreatic stellate cells facilitates pancreatic cancer cell invasion. EMBO Mol Med vol. 6, (4) 467-481.
Fearon AE, Grose RP(2014). Grb-ing receptor activation by the tail. Nat Struct Mol Biol vol. 21, (2) 113-114.
Yeste-Velasco M, Mao X, Grose R et al.(2014). Erratum:Identification of ZDHHC14 as a novel human tumour suppressor gene. J Pathol (2014); 232: 566-577)). Journal of Pathology vol. 234, (1)
Coleman SJ, Grose RP, Kocher HM(2014). Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma. J Hepatocell Carcinoma vol. 1, 43-54.
Yeste-Velasco M, Mao X, Grose R et al.(2014). Identification of ZDHHC14 as a novel human tumour suppressor: gene. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE vol. 34, S90-S90.
Fearon AE, Gould CR, Grose RP(2013). FGFR signalling in women's cancers. Int J Biochem Cell Biol vol. 45, (12) 2832-2842.
Guasti L, Candy Sze WC, McKay T et al.(2013). FGF signalling through Fgfr2 isoform IIIb regulates adrenal cortex development. Molecular and Cellular Endocrinology vol. 371, (1-2) 182-188.
Guasti L, Candy Sze WC, McKay T et al.(2013). FGF signalling through Fgfr2 isoform IIIb regulates adrenal cortex development. Mol Cell Endocrinol vol. 371, (1-2) 182-188.
Coleman S, Chioni A-M, Ghallab M et al. (2013). Nuclear Translocation of FGFR1 and FGF2 in Pancreatic Stellate Cells Is Necessary for Pancreatic Cancer Cell Invasion. GASTROENTEROLOGY. vol. 144, S98-S98.
Galavotti S, Bartesaghi S, Faccenda D et al.(2013). The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells. Oncogene vol. 32, (6) 699-712.
Robbez-Masson LJ, Bödör C, Jones JL et al.(2013). Functional analysis of a breast cancer-associated FGFR2 single nucleotide polymorphism using zinc finger mediated genome editing. PLoS One vol. 8, (11)
Meyer M, Müller A-K, Yang J et al.(2012). FGF receptors 1 and 2 are key regulators of keratinocyte migration in vitro and in wounded skin. J Cell Sci vol. 125, (Pt 23) 5690-5701.
Chioni A-M, Grose R(2012). FGFR1 cleavage and nuclear translocation regulates breast cancer cell behavior. J Cell Biol vol. 197, (6) 801-817.
Tsang SM, Brown L, Lin K et al.(2012). Non-junctional human desmoglein 3 acts as an upstream regulator of Src in E-cadherin adhesion, a pathway possibly involved in the pathogenesis of pemphigus vulgaris. J Pathol vol. 227, (1) 81-93.
Yeste-Velasco M, Mao X, Grose R et al.(2012). Identification of ZDHHC14 as a novel tumor suppressor gene commonly downregulated in human cancers. CANCER RESEARCH vol. 72,
Jarosz M, Robbez-Masson L, Chioni A-M et al.(2012). Fibroblast growth factor 22 is not essential for skin development and repair but plays a role in tumorigenesis. PLoS One vol. 7, (6)
Coleman SJ, Myrto-Chioni A, Grose RP et al. (2011). Investigating the Role of FGF Signaling in Pancreatic Cancer. GASTROENTEROLOGY. vol. 140, S714-S714.
Chioni A-M, Jones LJ, Grose RP(2011). A novel role for FGFR in breast cancer. CANCER RESEARCH vol. 71,
Tsang S, Liu L, Teh M et al. (2010). Novel role for human desmoglein 3 in regulating E-cadherin mediated adherens junctions through Src family kinase activation. JOURNAL OF INVESTIGATIVE DERMATOLOGY. vol. 130, S33-S33.
Yang J, Meyer M, Müller A-K et al.(2010). Fibroblast growth factor receptors 1 and 2 in keratinocytes control the epidermal barrier and cutaneous homeostasis. J Cell Biol vol. 188, (6) 935-952.
Turner N, Grose R(2010). Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer vol. 10, (2) 116-129.
Chioni A-M, Shao D, Grose R et al.(2010). Protein kinase A and regulation of neonatal Nav1.5 expression in human breast cancer cells: activity-dependent positive feedback and cellular migration. Int J Biochem Cell Biol vol. 42, (2) 346-358.
D'Amico G, Jones DT, Nye E et al.(2010). Regulation of lymphatic-blood vessel separation by endothelial Rac1 (vol 136, pg 4043, 2009). DEVELOPMENT vol. 137, (2) 359-359.
Tsang SM, Liu L, Teh M-T et al.(2010). Desmoglein 3, via an interaction with E-cadherin, is associated with activation of Src. PloS ONE vol. 5, (12)
D'Amico G, Jones DT, Nye E et al.(2009). Regulation of lymphatic-blood vessel separation by endothelial Rac1. Development vol. 136, (23) 4043-4053.
Muller A, Yang J, Meyer M et al. (2009). Control of epidermal barrier function and cutaneous homeostasis by FGF receptors 1 and 2. JOURNAL OF INVESTIGATIVE DERMATOLOGY. vol. 129, S85-S85.
Chioni A-M, Grose R(2009). Negative regulation of fibroblast growth factor 10 (FGF-10) by polyoma enhancer activator 3 (PEA3). Eur J Cell Biol vol. 88, (7) 371-384.
Chioni A-M, Grose R(2008). Organotypic modelling as a means of investigating epithelial-stromal interactions during tumourigenesis. Fibrogenesis Tissue Repair vol. 1, (1)
Grose R, Fantl V, Werner S et al.(2007). The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development. EMBO J vol. 26, (5) 1268-1278.
Grose R(2006). Fibroblast growth factor receptor 2-IIIb is a critical mediator of intercellular signalling in development and disease. J INVEST DERM SYMP P vol. 11, (1) 142-142.
Grose R, Dickson C(2005). Fibroblast growth factor signaling in tumorigenesis. Cytokine Growth Factor Rev vol. 16, (2) 179-186.
Reynolds LE, Conti FJ, Lucas M et al.(2005). Accelerated re-epithelialization in beta3-integrin-deficient- mice is associated with enhanced TGF-beta1 signaling. Nat Med vol. 11, (2) 167-174.
Grose R, Werner S(2004). Wound-healing studies in transgenic and knockout mice. Mol Biotechnol vol. 28, (2) 147-166.
Zhang HB, Dessimoz J, Beyer TA et al.(2004). Fibroblast growth factor receptor 1-lllb is dispensable for skin morphogenesis and wound healing. EUR J CELL BIOL vol. 83, (1) 3-11.
Grose R(2004). Common ground in the transcriptional profiles of wounds and tumors. Genome Biol vol. 5, (6)
Young P, Boussadia O, Halfter H et al.(2003). E-cadherin controls adherens junctions in the epidermis and the renewal of hair follicles. EMBO J vol. 22, (21) 5723-5733.
Petiot A, Conti FJA, Grose R et al.(2003). A crucial role for Fgfr2-IIIb signalling in epidermal development and hair follicle patterning. Development vol. 130, (22) 5493-5501.
Grose R(2003). Epithelial migration: open your eyes to c-Jun. Curr Biol vol. 13, (17) R678-R680.
Beyer TA, Werner S, Dickson C et al.(2003). Fibroblast growth factor 22 and its potential role during skin development and repair. EXP CELL RES vol. 287, (2) 228-236.
Werner S, Grose R(2003). Regulation of wound healing by growth factors and cytokines. Physiol Rev vol. 83, (3) 835-870.
Martin P, D'Souza D, Martin J et al.(2003). Wound healing in the PU.1 null mouse--tissue repair is not dependent on inflammatory cells. Curr Biol vol. 13, (13) 1122-1128.
Grose R, Werner S(2003). Wound healing studies in transgenic and knockout mice. A review. Methods Mol Med vol. 78, 191-216.
Wood W, Jacinto A, Grose R et al.(2002). Wound healing recapitulates morphogenesis in Drosophila embryos. NAT CELL BIOL vol. 4, (11) 907-912.
Grose R, Werner S, Kessler D et al.(2002). A role for endogenous glucocorticoids in wound repair. EMBO Rep vol. 3, (6) 575-582.
Grose R, Hutter C, Bloch W et al.(2002). A crucial role of beta 1 integrins for keratinocyte migration in vitro and during cutaneous wound repair. Development vol. 129, (9) 2303-2315.
Grose R, Werner S(2002). An aPPARently protective mechanism for keratinocytes in wounded skin. TRENDS MOL MED vol. 8, (4) 149-151.
Grose R, Harris BS, Cooper L et al.(2002). Immediate early genes krox-24 and krox-20 are rapidly up-regulated after wounding in the embryonic and adult mouse. Dev Dyn vol. 223, (3) 371-378.